TSC is classified as a neurocutaneous syndrome, or a phakomatosis (birth mark) disorder, with an incidence of about 1 in 6000 births, associated with two separate genes located on either chromosome 9 (TSC1) or 16 (TSC2). Here, TSC2 is linked to neurocutaneous syndrome.